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Abstract 
This prospective study aimed to compare the
efficacy of epidural (EDA) versus intravenous
(PCA) application of analgesics after lumbar
fusion. Fifty-two patients scheduled for elec-
tive  posterior  instrumented  lumbar  fusion
were  randomized  into  two  groups.  EDA
patients received an epidural catheter intraop-
eratively, and administration of ropivacain and
sulfentanil  was  started  after  a  normal  post-
operative wake-up test in the recovery room
area. PCA patients received intravenous opi-
oids in the post-operative period. Differences
between  EDA  and  PCA  groups  in  terms  of
patient satisfaction with respect to pain relief
were  not  significant.  Nevertheless,  EDA
patients reported less pain on the third day
after surgery. There were significantly more
side effects in the EDA group, including com-
plete reversible loss of sensory function and
motor  weakness.  There  were  no  major  side
effects, such as infection or persisting neuro-
logical deficits, in either group. The routine
use of epidural anesthesia for lumbar spine
surgery has too many risks and offers very lit-
tle advantage over PCA. 
Introduction
Effective post-operative pain control is not
only a matter of patient satisfaction, it  affects
the perioperative morbidity after major gener-
al, gynecological or thoracic surgeries consid-
erably  and  shortens  the  length  of  hospital
stay.
1-4
Intravenous  administration  of  opioids  has
proved superior to intramuscular injections in
the  management  of  post-operative  pain.  The
introduction  of  patient  controlled  analgesia
(PCA) has further improved patient satisfaction.
The  epidural  administration  (EDA)  of  anal-
gesics is another effective route to give anal-
gesics  during  post-operative  care.  Aggressive
pulmonary rehabilitation and early mobilization
are promoted by epidural analgesia.
5
Several  studies  have  compared  PCA  and
EDA in the management of pain after abdomi-
nal  surgery  and  gynecological  procedures.
Patients in the EDA group reported better pain
relief.  The  treatment  of  chronic  back  pain
patients with longstanding use of analgesics is
a difficult challenge after lumbar spine surgery
for degenerative disc disease.
The results of post-operative pain therapy
after lumbar spine surgery have so far been
inconsistent. Joshi and Sucato et al. compared
PCA  (morphine)  and  EDA  (fentanyl)  and
reported advantages in terms of post-operative
pain scores for the patients in the EDA group.
6,7
Other groups found no significant differences
between PCA and EDA in the post-operative
regimens after spinal fusion.
3,8
The following exploratory study focuses on
the difference between two routes of adminis-
tration  of  post-operative  analgesics,  the
epidural  and  intravenous  infusion,    after
instrumented posterior fusion surgery of the
lumbar spine. The aims of the study were to
quantify the doses of analgesics given accord-
ing to the route of administration and evaluate
differences  in  pain  assessment  and  patient
satisfaction. 
Materials and Methods
Patients scheduled for elective spinal sur-
gery of the lumbar spine for degenerative disc
disease were assigned randomly by a comput-
er program to one of two groups (1-12/2006).
The hypothesis of the study was that EDA is
more effective in comparison to intravenous
administration of analgesics for post-operative
treatment.
EDA patients (n=29) received an epidural
catheter  intraoperatively  whereas  PCA
patients  (n=23)  did  not.  All  patients  under-
went dorsal instrumented fusion at our institu-
tion performed by one of the two authors (TK
or  TN).  There  was  no  patient  drop  out.
Characteristics at baseline are summarized in
Table 1. There was no difference in gender dis-
tribution between the groups (P=0.41, Fisher’s
exact test). 
The study was approved by the local ethics
committee (Nr. 178-2004). The original appli-
cation for a blinded study with placement of an
epidural catheter and a placebo medication in
the PCA group was denied by the local ethics
committee on the grounds of poor risk/benefit
ratio for this group. Written informed consent
was obtained from all participating patients.
Inclusion criteria were defined as: age over
18 years, concurrence of radiological lumbar
disc disease and localization of persistent pain
under  conservative  treatment  for  over  three
months, elective posterior lumbar instrument-
ed  spinal  fusion  procedure  with  or  without
decompression.  A standard midline approach
was used. All patients received the same proto-
col for pre-operative preparation. Single dose
prophylactic  antibiotics  were  given.  The
Expedium screw-rod system (Fa. Depuy
®) was
implanted. Exclusion criteria were defined as:
infection, tumor or fracture as indication for
surgery,  missing  informed  patient  consent,
language barrier, mental retardation, pre-oper-
ative neurological deficit and known adverse
reactions to analgesics. Pre-operative use of
opioids  and  revision  procedures  were  not
defined as exclusion criteria.
EDA  patients  more  frequently  received  a
transforaminal  lumbar  intervertebral  fusion
(TLIF); however, posterior fusion with anterior
lumbar interbody fusion (ALIF) was more com-
mon in the PCA group. The differences did not
reach  statistical  significance  (Table  1).  The
decision for one or the other procedure was
made according to underlying pathology and
the  need  for  decompression  of  the  stenotic
segment.  
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Surgical technique
After completion of the spinal procedure, a
Tuohy  needle  (20  G,  B.  Braun,  Melsungen,
Germany) was placed from the lateral aspect of
the incision through a separate skin puncture
(Figure 1). The epidural catheter was threaded
through the needle and placed in the epidural
space under direct vision by the surgeon. The
catheter tip was advanced 3 cm cephalad to the
level of the instrumentation. The catheters were
fixed to the skin with 30 cm adhesive bandage
across  the  back  (Fixomull
®,  Fa.  Beiersdorf,
Germany). The catheter marking at skin level
was documented and checked during dressing
changes to watch for catheter dislocation.
After  surgery  all  patients  underwent  an
unremarkable wake-up test in the operating
theatre.  Afterwards  a  mixture  of  ropivacain
and sulfentanil was administered via catheter
in  the  recovery  room  (EDA)  starting  with  a
flow rate of 8 mL/h. An infusion pump was used
to  deliver  a  continuous  flow  using  a  50  ml
syringe (sufentanil 20 μg/4mL + 21 mL NaCl
0.9%+25  mL  ropivacain  0.2%).  All  patients
were nursed overnight in an intermediate care
unit.  Acute  pain  service  checked  on  the
patients, and infusion rate was adjusted to the
pain and sensomotory status. All patients were
offered additional pain medication on request.
PCA  patients  received  intravenous  pir-
itramid  using  an  infusion  pump.  The  treat-
ment was also started in the recovery room. A
fixed  concentration  of  30  mg  piritramid  (2
ampoules of 2 mL) with 46 mL of NaCl in per-
fusion syringe was prepared. The starting infu-
sion rate was 5 mL/h (3mg/h). The patients
were offered additional bolus doses using PCA
pump (2.5 mg) with a blocking time of 10 min.
Non-opioids  were  administered  for  both
groups (metamizol 3*1 g) and non-steroidal
anti-inflammatory drugs (diclofenac 2*75 mg).
These drugs were given by a structured regi-
men in the intermediate care facility during
the first 24 h after surgery. 
If the initial adjustment did not achieve ade-
quate pain control (VAS>5), IV sufentanil was
given.
One person not involved in the clincal care
of  the  patients  (FH)  recorded  the  following
data: dosage of intravenous and epidural med-
ication  used,  supplementary  analgesics
(NSAIDs,  metamizol,  paracetamol)  and  side
effects  of  medication,  pain  (visual  analog
scale), adverse reactions, sleep, appetite and
patient  satisfaction  with  the  post-operative
pain treatment (VAS). Mobility was evaluated
by  questions  concerning  walking,  climbing
stairs and bathroom activities. The same list of
items was checked at the day before the proce-
dure, at the day of the operation, and on the
1st,  3rd  and  8th  day  after  surgery  (primary
endpoint).  Results  on  the  VAS  were  trans-
ferred into a Numeric Rating Scale (NRS, 0-
10). Interval scales were used for the scoring
questions (0 = best, 10 = worst). Patients were
not aware of the kind of treatment given for
post-operative pain therapy before they were
anesthetized. All patients received a urinary
catheter  after  they  had  been  anesthetized
which was removed 24-48 h after surgery.
Statistical  analyses  were  performed  using
JMP,  version  5.1  (SAS  Institute,  Cary,  NC,
USA). The level of statistical significance was
set at P<0.05. The characteristics of the two
regimens were compared using the two-tailed
Fisher’s  exact  test,  Fisher-Freeman-Halton
test, the two-sample t-test or Mann-Whitney U
test as appropriate. VAS pain levels were ana-
lyzed by ANOVA. The data of this exploratory
study were collected with an objective but not
with a pre-specified key hypothesis and multi-
ple  test  adjustment  was,  therefore,  not  per-
formed. The 8
th day after surgery was specified
as  single  primary  endpoint  of  the  study.  All
other  endpoints  were  considered  subsidiary
and the interpretation of the results must be
considered exploratory.  
Results
The levels of pain (VAS) decreased signifi-
cantly during the course of the hospital stay for
both groups (ANOVA; time effect, P=0.027, F
test). The mean pre-operative score was high-
er for EDA patients 5.0±2.9, and 3.5±3.0 for
PCA  patients,  respectively.  There  was  an
advantage  for  the  pain  management  in  the
EDA group which showed a tendency to statis-
tical significance at day 3 (P=0.064) (Table 2).
Mean duration of EDA administration was
45.0±16.7 h. The average infusion rate of the
ropivacain/sulfentanil  combination  was
9.8±2.0 mL/h.  
The cumulative doses for the different anal-
gesics used are summarized in Table 3. PCA
patients received significantly higher doses of
sufentanil  intravenously.  The  doses  of  adju-
vant analgesics given did not differ between
both groups. PCA patients used fentanyl trans-
dermal patches significantly more often during
the observation period. 
The  following  minor  side  effects  were
recorded for EDA patients: loss of sensory func-
tion (n=6), motor weakness (n=3), failure or
displacement of EDA catheter (n=3). 
In the PCA group, three out of 23 patients
complained of nausea and vomiting. Cardio  -
pulmonary  reactions  were  not  reported  in
either group. Side effects occurred significant-
ly more often in the EDA group but all resolved
completely within hours. The EDA-administra-
tion was stopped until the documented normal-
ization of the sensory motor function and con-
tinued thereafter. There was no difference in
the  length  of  hospital  stay.  Mean  discharge
time was 13.9±6.3 days after surgery for the
EDA group and 13.4±2.4 for the PCA patients
(P=0.91,  t-test,  logarithmic  transformation),
respectively. The inpatient period for the pro-
cedure advised by the hospital administration
was 14 days. 
Patient satisfaction with post-operative pain
therapy was rated higher in the EDA group but
failed to meet statistical significance (Table 4).
Selected answers to items of the questionnaire
are listed in order of the time of evaluation.
Article
Figure  1.  Placement  of  the  epidural
catheter through a separate skin puncture
with the Tuohy needle.
Table 1. Baseline characteristics of the patients (min.-max. in parentheses).
Variable Epidural Intravenous P
Group 1 (n=29) Group 2 (n=23)
Mean age (years) 57 (22-80) 62 (28-86) 0.24
Gender (female/male) 15/14 9/14 0.36
Median duration of surgery (min) 168 (68-279) 163 (69-556) 0.72
Median number of fused levels 1 (1-8) 2 (1-11) 0.083
Iliac crest bone harvesting 15/29 7/23 0.16
Type of surgery
Posterior fusion 42
Posterior fusion + ALIF 7 13 0.07
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Pre-operative situation
One patient in each group was not able to
rise from a chair without assistance. One fur-
ther patient in the epidural group was in need
of  help  for  personal  hygiene  preparations.
Climbing stairs was not possible for one EDA
and  3  PCA  patients.  EDA  patients  reported
being  well  over  all  significantly  more  often
(P=0.019)
Day of surgery
All patients were helped to carry out hygiene
tasks. EDA patients reported “being well over
all” significantly more often about “being well
over  all”  (P=0.019).  Most  patients  in  both
groups suffered from loss of appetite (53% vs.
60%,  P>0.05).  There  was  no  difference  in
results  of  VAS  and  mobilization  between
groups.
First day after surgery
Analysis  did  not  show  evidence  of  differ-
ences between the groups in terms of pain,
mobilization, need of assistance for activities
of daily living, appetite, problems during phys-
ical therapy or general well being. There were
significantly fewer reports of disturbances of
night sleep due to pain in EDA patients (26%
vs. 80%, P=0.005). Satisfaction with the pain
management  was  rated  higher  in  the  PCA
group (2.8±2.7 vs. 1.8±1.8, P=0.18).
Third day after surgery
Scores were assessed after removal of the
epidural  catheter.  Suffering  from  pain  was
rated lower for the EDA group, but did not gain
statistical  significance  (P=0.064).  Mobili-
zation also improved faster for EDA patients.
Eighty-five percent of the EDA patients were
able to transfer and walk short distances with-
out  help  in  comparison  to  61%  in  Group  2
(P=0.058). Most of the Group 1 patients were
independent in the bathroom (85% vs. 52%,
P=0.014).
Eighth day after surgery
EDA  patients  showed  an  advantage  when
climbing stairs independently (74% vs. 40%,
P=0.034).  These  patients  reported  loss  of
appetite less frequently (P=0.044).
There was no difference in answers to gen-
eral well being, the course of the hospital stay,
the level of pain at that moment and the over-
all satisfaction with pain management.
Mean costs for all analgesics used during
the hospital stay were significantly higher for
EDA patients (31.07±21.72 euros vs. 5.10±4.14
euros, P<0.0001). These numbers are based
on the prices of our hospital pharmacy in euros
and do not include auxiliary costs.
Discussion
Potential  undertreatment  of  pain  in  the
post-operative period because of concerns of
safety and complications, such as opioid relat-
ed respiratory depression, has been reported.
5
The  proportion  of  patients  with  inadequate
pain therapy is reported to be up to one half.
5
This  risk  is  especially  high  in  patients  who
have undergone surgery for chronic low back
pain. These patients are often accustomed to
treatment  with  potent  analgesics  including
opioids. The introduction of the epidural appli-
cation route for analgesics was very successful
for the treatment of post-operative pain after
general surgery or gynecological procedures.
9
Following spinal surgery, this administration
route  can  interfere  with  the  post-operative
neurological  observation  of  the  patient,  and
increase the  risk of delay in diagnosis and
treatment  of  post-operative  complications
because  of  masking  the  symptoms.
4 Some
authors recommend delaying the initiation of
the epidural analgesia until the next day and
to, therefore, minimize interference with post-
operative neurological observation.
1
In many centers, PCA is the standard tech-
nique of choice for pain therapy after spinal
procedures.  Since  this  method  complements
the individual variation of pain perception, it
is superior to continuous intravenous admin-
istration.  However,  a  PCA  bolus-on-demand
regimen  does  not  address  the  issue  of  pre-
emptive  pain  treatment,  especially  the  first
night after surgery. This issue is reflected in
our results of less night sleep disturbance in
the EDA group with continuous opioid admin-
istration.  
Joshi  et  al. found  significant  lower  pain
scores after laminectomy for patients with con-
tinuous  epidural  administration  of  fentanyl
compared to intravenous morphine infusion.
6
After  anterior  scoliosis  correction,  patients
Article
Table 3. Cumulative doses of all analgesics administered during the observation period
(mean ± SD).
Medication Morphine Epidural Intravenous P
equivalents Group 1 (n=29) Group 2 (n=23)
Epidural
Ropivacain (g)   1.19±1.47 --
Sufentanil (μg) 1000 2.24±0.98
Intravenous
Sufentanil (μg) 1000 7.59±23.21 14.24±20.25 0.053
Piritramid (mg) 0.7 24.09±92.36 53.55±120.10 0.14
Paracetamol (g) 0.91±1.10 1.28±1.53 0.32
Metamizol (g) 8.38±7.42 7.64±6.67 0.71
Enteral/rectal
NSAID (g) 1.44±0.62 1.42±0.85 0.93
Morphine (mg) 1 61.83±188.68 130.44±343.58 0.30
Tramadol (g) 0.1 0.50±0.64 0.40±0.51 0.50
Transdermal
Fentanyl (μg) 100 1.72±9.28 20.09±57.65 0.045
Table 2. Results of pain assessment after transforming the VAS-markings of the patients
into the numeric rating scale (mean ± SD, numeric rating scale 0-10).
Epidural Intravenous P
Group 1 (n=29) Group 2 (n=23)
Day before surgery 5.0±2.9 3.6±3.0 0.093
Day of surgery 4.0±3.7 5.9±4.2 0.292
1
st post-op. day 3.8±2.9 3.5±2.9 0.733
3
rd post-op. day 3.0±2.6 4.5±3.0 0.064
8
th post-op. day 2.2±2.3 3.3±3.0 0.213
Table 4. Patient satisfaction with pain therapy for both groups (mean ± SD 0=excellent,
10=very poor).
Epidural Intravenous P
Group 1 (n=29) Group 2 (n=23)
Day of surgery 1.88±0.54 2.04±0.88 0.874
1
th post-op. day 2.28±0.45 2.63±0.51 0.602
3
rd post-op. day 2.66±2.52 3.30±2.95 0.416
8
th post-op. day 1.98±2.40 3.39±3.44 0.153[page 30] [Orthopedic Reviews 2010; 2:e9]
benefit  from  epidural  ropivacain  infusion
through  improved  analgesia,  less  vomiting/
nausea and earlier return of bowel function.
1,7
The main advantage of epidural application is
the lower opioid dosage necessary to achieve
pain relief and, therefore, less general opioid
side effects.
9 The biggest drawback is the pres-
ence of an additional foreign body in the surgi-
cal area. There is the potential risk of iatro-
genic infection and delay in the treatment of
post-operative complications, such as epidural
hematoma, as the cause of the development of
sensory or motor impairment.
This study has limitations in that, despite
the randomization, the groups differ in fusion
length. However, there was no significant dif-
ference  in  median  pre-operative  pain  score
(VAS)  between  the  two  groups.  Since  there
was also no statistical difference in reported
pain levels reported at day 8 after surgery, we
assume that the comparison of both groups is
correct and results were not altered by con-
founding variables. It was surprising that the
only statistical tendency on the NRS numbers
was found at day 3, since the EDA was removed
after an average 45 h. 
The incidence of minor side effects in this
study  was  minimal.  Despite  the  small  num-
bers, every report of a neurological deficit in a
patient soon after spinal surgery is alarming
(especially  to  the  responsible  surgeon)  and
may  cause  additional  diagnostic  efforts  and
costs, for example, for a control CT scan to rule
out complications such as epidural hematoma.
Fortunately, we did not observe major compli-
cations like infection or neurological deficits,
as reported previously.
10 Minor advantages for
the  EDA  patients  in  the  mobilization  areas
might be caused by less sedation through the
systemic opioid effects. These results are in
contrast to the numbers of Fisher et al. They
could not achieve earlier mobilization in the
EDA group.
3 The use of two epidural catheters
provided a better post-operative analgesia with
fewer side effects and higher patient satisfac-
tion  after  anterior  scoliosis  correction  in
another study.
1
We  did  not  confirm  the  catheter  position
radiographically,  as  suggested  in  the  litera-
ture.
1,3 We felt there was no need for this as we
positioned the catheter under direct vision.
The use of patient controlled epidural infu-
sion did not show significantly better results
than another earlier report. Eleven out of 39
patients were reported to cross over to a PCA
regimen and there was also no difference in
patient satisfaction.
3
Different  medication  dose  regimens  have
been reported for PCA and EDA in the litera-
ture.
1,3,8,11,12 Since we had already observed sen-
sory and motor impairment, we are sure we did
not underdose EDA in our patients. However,
there may be another more effective regimen.
The combination of a local anesthetic plus opi-
oid seems to be more effective than opioids
alone.
1,8Urinary retention is a frequent problem
of  EDA  use.  Since  all  our  patients  received
Foley catheterization during the pre-operative
preparation we did not have any such problems.
The length of the hospital stay is not a valid
measure of treatment outcome because of the
economic confounders, and the discharge of
our patients was more influenced by the group-
ing  of  the  patient  (DRG-diagnosis  related
groups) than by pain and mobilization of the
patients. Since there were no striking statisti-
cal differences between either regimen in this
exploratory study, they may both be selected for
post-operative pain management after lumbar
instrumented  spinal  fusion  according  to  the
preferences of the staff and the patient. 
The use of epidural anesthesia routinely for
spine surgery provides too many risks and very
little additional benefit from PCA. Neurological
deficit confusing the neurological exam, and
increased costs are the major reasons why we
do not use epidural anesthesia after lumbar
spine fusion.
The  pre-operative  placement  of  the  EDA
catheter and the administration of opioids dur-
ing surgery contribute to more stable hypoten-
sion and less bleeding during the procedure
and  these  may  be  advantages  in  EDA  treat-
ment.
12 Since we placed the catheter after com-
pleting  the  spinal  procedure  we  have  not
proved this possible positive effect of EDA. 
Conclusions
Epidural administration of analgesia is an
effective route for post-operative pain manage-
ment after lumbar spinal instrumented fusion.
But patients in the EDA group experienced sig-
nificantly  more  minor  side  effects  which
demanded more attention by the surgeon in
charge and the nursing staff to avoid delay in
case  of  possible  surgical  complications.
Patient  satisfaction  with  post-operative  pain
treatment was equally positive with the intra-
venous regimen. At present we only use PCA in
the post-operative period after lumbar spine
fusion.
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